Rheumatoid arthritis and work: The impact of rheumatoid arthritis on absenteeism and presenteeism

Best Practice and Research: Clinical Rheumatology

Volumn 29, Issue 3, 2015, Pages 495-511

  Verstappen, Suzanne M M ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Absenteeism; Biologic therapy; Indirect costs; Presenteeism; Rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG;

ABSENTEEISM; ARTICLE; BIOLOGICAL THERAPY; HEALTH CARE COST; HUMAN; MEDICAL LEAVE; PRESENTEEISM; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; WORK; ARTHRITIS, RHEUMATOID; DISABILITY; ECONOMICS; PATHOPHYSIOLOGY; PRODUCTIVITY;

ABSENTEEISM; ARTHRITIS, RHEUMATOID; BIOLOGICAL THERAPY; DISABILITY EVALUATION; EFFICIENCY; HUMANS; PRESENTEEISM; SICK LEAVE; WORK;

EID: 84948383960     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2015.06.001     Document Type: Review

References (56)

1. M.F. Drummond, M.J. Sculpher, and G.W. Torrance Methods for economic evaluation of health care programmes 2005 Oxford Medical Publications Oxford
2. K. Tang, R. Escorpizo, D.E. Beaton, and et al. Measuring the impact of arthritis on worker productivity: perspectives, methodologic issues, and contextual factors J Rheumatol 38 2011 Aug 1776 1790
3. L.M. Lamers, W.J. Meerding, J.L. Severens, and et al. The relationship between productivity and health-related quality of life: an empirical exploration in persons with low back pain Qual Life Res 14 2005 Apr 805 813
4. S.M. Verstappen, J.W. Bijlsma, H. Verkleij, and et al. Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys Arthritis Rheum 51 2004 Jun 15 488 497
5. W. Burton, A. Morrison, R. MacLean, and et al. Systematic review of studies of productivity loss due to rheumatoid arthritis Occup Med (Lond) 56 2006 Jan 18 27
6. T. Sokka, H. Kautiainen, T. Pincus, and et al. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study Arthritis Res Ther 12 2010 R42
7. M. Neovius, J.F. Simard, and J. Askling How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop? Ann Rheum Dis 70 2011 Jun 1010 1015
8. S. Mattke, A. Balakrishnan, G. Bergamo, and et al. A review of methods to measure health-related productivity loss Am J Manag Care 13 2007 Apr 211 217
9. I. Robertson, D. Leach, N. Doerner, and et al. Poor health but not absent: prevalence, predictors, and outcomes of presenteeism J Occup Environ Med 54 2012 Nov 1344 1349
10. C.D. Hansen, and J.H. Andersen Going ill to work-what personal circumstances, attitudes and work-related factors are associated with sickness presenteeism? Soc Sci Med 67 2008 Sep 956 964
11. M.V. Pauly, S. Nicholson, D. Polsky, and et al. Valuing reductions in on-the-job illness: 'presenteeism' from managerial and economic perspectives Health Econ 17 2008 Apr 469 485
12. R. Sogaard, J. Sorensen, L. Linde, and et al. The significance of presenteeism for the value of lost production: the case of rheumatoid arthritis Clin Outcomes Res 2 2010 105 112
13. R. Escorpizo, C. Bombardier, A. Boonen, and et al. Worker productivity outcome measures in arthritis J Rheumatol 34 2007 Jun 1372 1380
14. K. Tang, A. Boonen, S.M. Verstappen, and et al. Worker productivity outcome Measures: OMERACT filter evidence and agenda for future research J Rheumatol 41 2014 Jan 165 176
15. P. Putrik, S. Ramiro, T.K. Kvien, and et al. Inequities in access to biologic and synthetic DMARDs across 46 European countries Ann Rheum Dis 73 2014 Jan 198 206
16. S.M. Verstappen, A. Boonen, J.W. Bijlsma, and et al. Working status among Dutch patients with rheumatoid arthritis: work disability and working conditions Rheumatol (Oxford) 44 2005 Feb 202 206
17. M.M. ter Wee, W.F. Lems, H. Usan, and et al. The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review Ann Rheum Dis 71 2012 Feb 161 171
18. S.M. Verstappen, K.D. Watson, M. Lunt, and et al. Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register Rheumatol (Oxford) 49 2010 Aug 1570 1577
19. R.F. van Vollenhoven, M.A. Cifaldi, S. Ray, and et al. Improvement in work place and household productivity for patients with early rheumatoid arthritis treated with adalimumab plus methotrexate: work outcomes and their correlations with clinical and radiographic measures from a randomized controlled trial companion study Arthritis Care Res (Hoboken) 62 2010 Feb 226 234
20. J.S. Smolen, C. Han, D. van der Heijde, and et al. Infliximab treatment maintains employability in patients with early rheumatoid arthritis Arthritis Rheum 54 2006 Mar 716 722
21. J.C. Cole, T. Li, P. Lin, and et al. Treatment impact on estimated medical expenditure and job loss likelihood in rheumatoid arthritis: re-examining quality of life outcomes from a randomized placebo-controlled clinical trial with abatacept Rheumatology (Oxford) 47 2008 Jul 1044 1050
22. V. Bejarano, M. Quinn, P.G. Conaghan, and et al. Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis Arthritis Rheum 59 2008 Oct 15 1467 1474
23. A. Kavanaugh, J.S. Smolen, P. Emery, and et al. Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis Arthritis Rheum 61 2009 Nov 15 1592 1600
24. A. Anis, W. Zhang, P. Emery, and et al. The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study Rheumatol (Oxford) 48 2009 Oct 1283 1289
25. J.M. Hazes, P. Taylor, V. Strand, and et al. Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol Rheumatol (Oxford) 49 2010 Oct 1900 1910
26. W. Zhang, H. Sun, P. Emery, and et al. Does achieving clinical response prevent work stoppage or work absence among employed patients with early rheumatoid arthritis? Rheumatol (Oxford) 51 2012 Feb 270 274
27. J.K. Eriksson, M. Neovius, J. Bratt, and et al. Biological vs conventional combination treatment and work loss in early rheumatoid arthritis: a randomized trial JAMA Intern 173 2013 1407 1414
28. C.F. Allaart, F.C. Breedveld, and B.A. Dijkmans Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study J Rheumatol Suppl 80 2007 Nov 25 33
29. W. Zhang, N. Bansback, D. Guh, and et al. Short-term influence of adalimumab on work productivity outcomes in patients with rheumatoid arthritis J Rheumatol 35 2008 Sep 1729 1736
30. T. Mittendorf, B. Dietz, R. Sterz, and et al. Personal and economic burden of late-stage rheumatoid arthritis among patients treated with adalimumab: an evaluation from a patient's perspective Rheumatol (Oxford) 47 2008 Feb 188 193
31. K. Pavelka, Z. Szekanecz, N. Damjanov, and et al. Induction of response with etanercept-methotrexate therapy in patients with moderately active rheumatoid arthritis in Central and Eastern Europe in the PRESERVE study Clin Rheumatol 32 2013 Sep 1275 1281
32. W.V. Epstein, C.J. Henke, E.H. Yelin, and et al. Effect of parenterally administered gold therapy on the course of adult rheumatoid arthritis Ann Intern Med 114 1991 Mar 15 437 444
33. G. Kobelt, K. Eberhardt, and P. Geborek TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden Ann Rheum Dis 63 2004 Jan 4 10
34. K. Laas, R. Peltomaa, H. Kautiainen, and et al. Pharmacoeconomic study of patients with chronic inflammatory joint disease before and during infliximab treatment Ann Rheum Dis 65 2006 Jul 924 928
35. P. Farahani, M. Levine, K. Gaebel, and et al. Community-based evaluation of etanercept in patients with rheumatoid arthritis J Rheumatol 33 2006 Apr 665 670
36. T. Olofsson, M. Englund, T. Saxne, and et al. Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study Ann Rheum Dis 69 2010 Dec 2131 2136
37. J. Augustsson, M. Neovius, C. Cullinane-Carli, and et al. Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry) Ann Rheum Dis 69 2010 Jan 126 131
38. K. Kruger, J. Wollenhaupt, H.M. Lorenz, and et al. Reduction in sickness absence in patients with rheumatoid arthritis receiving adalimumab: data from a German noninterventional study Rheumatol Int 32 2012 Dec 3977 3983
39. K. Nair, V. Ghushchyan, and A. Naim Effectiveness and costs of TNF-alpha blocker use for patients with rheumatoid arthritis Am Health Drug Benefits 6 2013 Mar 126 136
40. D. Hone, A. Cheng, C. Watson, and et al. Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States Arthritis Care Res (Hoboken) 65 2013 Oct 1564 1572
41. D.A. Machado, R.M. Guzman, R.M. Xavier, and et al. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region J Clin Rheumatol 20 2014 Jan 25 33
42. J.L. Hoving, G.M. Bartelds, J.K. Sluiter, and et al. Perceived work ability, quality of life, and fatigue in patients with rheumatoid arthritis after a 6-month course of TNF inhibitors: prospective intervention study and partial economic evaluation Scand J Rheumatol 38 2009 246 250
43. M.M. Herenius, J.L. Hoving, J.K. Sluiter, and et al. Improvement of work ability, quality of life, and fatigue in patients with rheumatoid arthritis treated with adalimumab J Occup Environ Med 52 2010 Jun 618 621
44. H.G. Raterman, J.L. Hoving, M.T. Nurmohamed, and et al. Work ability: a new outcome measure in rheumatoid arthritis? Scand J Rheumatol 39 2010 Mar 127 131
45. H. Furuya, T. Kasama, T. Isozaki, and et al. Effect of TNF antagonists on the productivity of daily work of patients with rheumatoid arthritis J Multidiscip Healthc 6 2013 25 30
46. W.B. Brouwer, M.A. Koopmanschap, and F.F. Rutten Productivity losses without absence: measurement validation and empirical evidence Health Policy 48 1999 Jul 13 27
47. D. Lerner, B.C. Amick III, W.H. Rogers, and et al. The work limitations questionnaire Med Care 39 2001 Jan 72 85
48. M.C. Reilly, A.S. Zbrozek, and E.M. Dukes The validity and reproducibility of a work productivity and activity impairment instrument Pharmacoeconomics 4 1993 Nov 353 365
49. K. Tuomi, J. Ilmarinen, A. Jahkola, and et al. Work ability index 2nd ed. 1998 Finish Institute of Occupational Health Helsinki
50. R.Z. Goetzel, S.R. Long, R.J. Ozminkowski, and et al. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers J Occup Environ Med 46 2004 Apr 398 412
51. M.A. Koopmanschap, and F.F. Rutten A practical guide for calculating indirect costs of disease Pharmacoeconomics 10 1996 Nov 460 466
52. S.M. Verstappen, A. Boonen, H. Verkleij, and et al. Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity Ann Rheum Dis 64 2005 Dec 1754 1760
53. R.J. Ozminkowski, R.Z. Goetzel, S. Chang, and et al. The application of two health and productivity instruments at a large employer J Occup Environ Med 46 2004 Jul 635 648
54. W. Zhang, M.A. Gignac, D. Beaton, and et al. Productivity loss due to presenteeism among patients with arthritis: estimates from 4 instruments J Rheumatol 37 2010 Sep 1805 1814
55. W. Zhang, J.A. Chiu, N. Bansback, and et al. An update on the measurement of productivity losses due to rheumatoid diseases Best Pract Res Clin Rheumatol 26 2012 Oct 585 597
56. E. Yelin, L. Trupin, P. Katz, and et al. Association between etanercept use and employment outcomes among patients with rheumatoid arthritis Arthritis Rheum 48 2003 Nov 3046 3054